Clinical Trial Update: ABR-217620 in Patients With Advanced Non-Small Cell Lung Cancer, Renal Clear Cell Carcinoma or Pancreatic Cancer [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update of ABR-217620 in patients with advanced non-small cell lung cancer, renal cell carcinoma, and pancreatic cancer; the study status …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer
• Pancreatic Cancer
• Renal Cell Carcinoma

Drugs mentioned

• ABR-217620

Snippet

Sponsor: Active Biotech AB | Conditions: Non-Small-Cell Lung Carcinoma, Renal Cell Carcinoma | Phase 1 | Status: COMPLETED